Ci Pan

570 total citations
37 papers, 405 citations indexed

About

Ci Pan is a scholar working on Oncology, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ci Pan has authored 37 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Neurology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ci Pan's work include Neuroblastoma Research and Treatments (12 papers), Acute Lymphoblastic Leukemia research (12 papers) and Acute Myeloid Leukemia Research (7 papers). Ci Pan is often cited by papers focused on Neuroblastoma Research and Treatments (12 papers), Acute Lymphoblastic Leukemia research (12 papers) and Acute Myeloid Leukemia Research (7 papers). Ci Pan collaborates with scholars based in China, United States and Canada. Ci Pan's co-authors include Hui-liang Xue, Jingyan Tang, Jing Chen, Shuhong Shen, Yijin Gao, Jiaoyang Cai, Jing Chen, Jingyan Tang, Yanjing Tang and Xiang Wang and has published in prestigious journals such as International Journal of Cancer, Cancer Letters and BioMed Research International.

In The Last Decade

Ci Pan

36 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ci Pan China 14 157 109 107 96 82 37 405
Susan R. Wiersma United States 13 175 1.1× 48 0.4× 78 0.7× 260 2.7× 103 1.3× 16 517
Eric S. Schafer United States 11 200 1.3× 159 1.5× 92 0.9× 95 1.0× 34 0.4× 36 391
Sidharth Totadri India 9 74 0.5× 85 0.8× 51 0.5× 82 0.9× 50 0.6× 41 254
S Banavali India 10 244 1.6× 159 1.5× 129 1.2× 139 1.4× 16 0.2× 25 497
Artit Ungkanont Thailand 15 64 0.4× 65 0.6× 52 0.5× 263 2.7× 34 0.4× 28 447
Koichiro Ikuta Japan 10 139 0.9× 90 0.8× 128 1.2× 429 4.5× 24 0.3× 22 553
April Sorrell United States 9 201 1.3× 71 0.7× 90 0.8× 314 3.3× 42 0.5× 18 498
Toshiaki Ishida Japan 11 58 0.4× 32 0.3× 112 1.0× 63 0.7× 93 1.1× 51 439
Heidi Segers Belgium 14 102 0.6× 107 1.0× 126 1.2× 91 0.9× 26 0.3× 36 465
WA Kamps Netherlands 7 271 1.7× 123 1.1× 67 0.6× 207 2.2× 18 0.2× 11 394

Countries citing papers authored by Ci Pan

Since Specialization
Citations

This map shows the geographic impact of Ci Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ci Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ci Pan more than expected).

Fields of papers citing papers by Ci Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ci Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ci Pan. The network helps show where Ci Pan may publish in the future.

Co-authorship network of co-authors of Ci Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ci Pan. A scholar is included among the top collaborators of Ci Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ci Pan. Ci Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tianyi, Mingxuan Feng, Xinyu Wan, et al.. (2021). Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Cell Transplantation. 30. 2139989353–2139989353. 19 indexed citations
2.
Xin, Chao, Jianmin Zhu, Song Gu, et al.. (2020). CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment. Cancer Immunology Immunotherapy. 69(11). 2333–2343. 16 indexed citations
3.
Pan, Ci, et al.. (2019). Association of image-defined risk factors, tumor resectability, and prognosis in children with localized neuroblastoma. World Journal of Pediatrics. 15(6). 572–579. 23 indexed citations
4.
Cai, Mengxin, Tianyi Wang, Ci Pan, et al.. (2019). Investigating the potential benefit of second biopsy of residual mass in pediatric mature B cell non-Hodgkin lymphoma. Pediatric Hematology and Oncology. 36(2). 113–121.
5.
Chen, Xiaoxiao, Yanjing Tang, Jing Chen, et al.. (2019). Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia. Frontiers of Medicine. 13(3). 378–387. 14 indexed citations
6.
Shen, Shuhong, Jiaoyang Cai, Jing Chen, et al.. (2018). Long‐term results of the risk‐stratified treatment of childhood acute lymphoblastic leukemia in China. Hematological Oncology. 36(4). 679–688. 22 indexed citations
7.
Gao, Yijin, et al.. (2017). Treatment Outcome of Children With Multisystem Langerhans Cell Histiocytosis: The Experience of a Single Children’s Hospital in Shanghai, China. Journal of Pediatric Hematology/Oncology. 40(1). e9–e12. 10 indexed citations
8.
Cai, Jiaoyang, Ci Pan, Yanjing Tang, et al.. (2017). Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, China. Journal of Cancer Research and Clinical Oncology. 143(7). 1327–1335. 7 indexed citations
9.
Yuan, Xiaojun, Huanmin Wang, Hui Jiang, et al.. (2016). Multidisciplinary effort in treating children with hepatoblastoma in China. Cancer Letters. 375(1). 39–46. 27 indexed citations
10.
Pan, Ci, Jiaoyang Cai, Min Xu, et al.. (2015). Renal tumor in developing countries: 142 cases from a single institution at Shanghai, China. World Journal of Pediatrics. 11(4). 326–330. 9 indexed citations
11.
Song, Lei, et al.. (2013). [Clinical study of combined treatment of remifemin and paroxetine for perimenopausal depression].. PubMed. 93(8). 600–2. 8 indexed citations
12.
Wang, Xiang, Jingyan Tang, Hui-liang Xue, et al.. (2012). Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia. Frontiers of Medicine. 6(4). 416–420. 65 indexed citations
13.
Gao, Yijin, et al.. (2012). Risk-adapted chemotherapy without procarbazine in treatment of children with Hodgkin lymphoma. World Journal of Pediatrics. 9(1). 32–35. 1 indexed citations
14.
Cai, Jiaoyang, Ci Pan, Yanjing Tang, et al.. (2011). Minimal Residual Disease is a Prognostic Marker for Neuroblastoma With Bone Marrow Infiltration. American Journal of Clinical Oncology. 35(3). 275–278. 18 indexed citations
15.
Tang, Jingyan, Yin Liu, Jing Chen, et al.. (2011). Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China. International Journal of Hematology. 93(5). 610–617. 7 indexed citations
16.
Liu, Yin, et al.. (2009). Cost of childhood acute lymphoblastic leukemia care in Shanghai, China. Pediatric Blood & Cancer. 53(4). 557–562. 39 indexed citations
17.
Li, Juan, Jing Tang, Jing Chen, et al.. (2008). Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leukemia & lymphoma. 49(3). 488–494. 14 indexed citations
18.
Cai, Jiaoyang, Yanjing Tang, Limin Jiang, et al.. (2007). Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma. Pediatric Blood & Cancer. 49(7). 952–957. 12 indexed citations
19.
Tang, Jingyan, Hui-liang Xue, Ci Pan, et al.. (2003). A homoharringtonine‐based regimen for childhood acute myelogenous leukemia. Medical and Pediatric Oncology. 41(1). 70–72. 5 indexed citations
20.
Tang, Jing, Ci Pan, Jing Chen, et al.. (2002). Outcome of B‐cell non‐Hodgkin lymphoma protocol CCCG‐B NHL97: A report from Chinese multi‐center cooperative group. Medical and Pediatric Oncology. 39(3). 212–214. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan R. Wiersma Breakdown of academic impact, for papers by Eric S. Schafer Breakdown of academic impact, for papers by Sidharth Totadri Breakdown of academic impact, for papers by S Banavali Breakdown of academic impact, for papers by Artit Ungkanont Breakdown of academic impact, for papers by Koichiro Ikuta Breakdown of academic impact, for papers by April Sorrell Breakdown of academic impact, for papers by Toshiaki Ishida Breakdown of academic impact, for papers by Heidi Segers Breakdown of academic impact, for papers by WA Kamps
Rankless by CCL
2026